TRPV4 promotes acoustic wave-mediated BBB opening via Ca<sup>2+</sup>/PKC-δ pathway.
Authors: Liao WH, Hsiao MY, Kung Y, Liu HL, Béra JC, Inserra C, Chen WS
Numerous studies have shown the ability of low-energy acoustic waves such as focused ultrasound or shockwave to transiently open blood-brain barrier (BBB) and facilitate drug delivery to the brain. Preclinical and clinical evidences have well demonstrated the efficacy and safety in treating various brain disorders. However, the molecular mechanisms of acoustic waves on the BBB are still not fully understood. The present study aimed at exploring the possible molecular mechanisms of acoustic wave stimulation on brains. The left hemisphere of the rat's brain was treated with pulsed ultrasound from a commercial focused shockwave or a planar ultrasound device, and the right hemisphere served as a control. One hour after the mechanical wave stimulation or overnight, the rats were sacrificed and the brains were harvested for protein or histological analysis. Agonists and antagonists related to the signal transduction pathways of tight junction proteins were used to investigate the possible intracellular mechanisms. Intracellular signal transduction analysis shows calcium influx through transient receptor potential vanilloid 4 (TRPV4) channels, and the activation of PKC-δ pathway to mediate dissociation of ZO-1 and occludin after acoustic wave stimulation. The activation of TRPV4 or PKC-δ signaling further increased the expression level of TRPV4, suggesting a feedback loop to regulate BBB permeability. Moreover, the tight junction proteins dissociation can be reversed by administration of PKC-δ inhibitor and TRPV4 antagonist. The present study shows the crucial role of TRPV4 in acoustic wave-mediated BBB permeability, specifically its effect on compromising tight junction proteins, ZO-1 and occludin. Our findings provide a new molecular perspective to explain acoustic wave-mediated BBB opening. Moreover, activation of TRPV4 by agonists may reduce the threshold intensity level of acoustic waves for BBB opening, which may prevent undesirable mechanical damages while maintaining efficient BBB opening.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To investigate how acoustic wave stimulation (ultrasound/shockwave) alters blood–brain barrier permeability by testing whether TRPV4-mediated calcium influx and downstream PKC-δ signaling disrupt tight junction proteins.
Animal model / Human subject
rat, Sprague–Dawley, adult, male
Disease model
healthy
Targeted brain region(s)
Cerebral Hemisphere
Cargo name and characteristics
TRPV4 modulators (TRPV4 agonists and TRPV4 antagonists — small-molecule ion channel modulators) and a PKC-δ inhibitor (small-molecule kinase inhibitor).
Outcomes and Safety
Summary of Outcomes
Acoustic waves opened the BBB by activating TRPV4-mediated calcium influx and PKC-δ signaling.
Duration of biological effect
18 hours
Safety-related matter
No significant inflammation or apoptosis observed.
Brain Region
Ultrasound Parameters
Ultrasound instrument
commercial focused shockwave and planar ultrasound transducer
FUS Frequency
1 MHz
FUS Intensity
0.5 W/cm²
FUS Pressure
not reported
FUS Mode
pulsed
Pulse duration
500 ms
Duration of a single FUS session
not reported
Treatment frequency
Single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search